Edition:
United States

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

112.61USD
19 Sep 2018
Change (% chg)

$-0.82 (-0.72%)
Prev Close
$113.43
Open
$113.43
Day's High
$113.46
Day's Low
$112.35
Volume
189,202
Avg. Vol
181,584
52-wk High
$114.50
52-wk Low
$75.28

Chart for

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.87
Market Cap(Mil.): $16,184.65
Shares Outstanding(Mil.): 142.68
Dividend: 0.37
Yield (%): 1.30

Financials

  RMD.N Industry Sector
P/E (TTM): 35.99 47.56 32.45
EPS (TTM): 3.15 -- --
ROI: 16.02 8.31 12.63
ROE: 22.57 12.22 14.80

EU mergers and takeovers (Sept 18)

BRUSSELS, Sept 18 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Sep 18 2018

NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.

Sep 10 2018

UPDATE 1-NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Sept 11 Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.

Sep 10 2018

NZ's Fisher & Paykel Healthcare files patent infringement complaint against ResMed

Sept 11 Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint in the United States against ResMed .

Sep 10 2018

UPDATE 1-NZ's Fisher & Paykel cuts FY guidance on ResMed-linked legal costs

Sept 3 New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

Sep 02 2018

NZ's Fisher & Paykel Healthcare cuts FY guidance on higher expected legal costs

Sept 3 New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

Sep 02 2018

BRIEF-Infoscan Signs LoI With ResMed Polska

* REPORTED ON WEDNESDAY IT HAS SIGNED LETTER OF INTENT (LOI) WITH RESMED POLSKA ON COOPERATION

Aug 09 2018

BRIEF-Resmed Inc Q3 GAAP Earnings Per Share $0.76

* RESMED INC ANNOUNCES RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2018

Apr 26 2018

BRIEF-Resmed Says Co Entered Certain Amended And Restated Credit Agreement, Dated As Of Closing Date

* RESMED SAYS ON APRIL 17, 2018 ('CLOSING DATE'), CO ENTERED CERTAIN AMENDED AND RESTATED CREDIT AGREEMENT, DATED AS OF CLOSING DATE - SEC FILING

Apr 19 2018

BRIEF-ResMed Hires Bobby Ghoshal As First Chief Technology Officer

* RESMED HIRES BOBBY GHOSHAL AS FIRST CHIEF TECHNOLOGY OFFICER Source text for Eikon: Further company coverage:

Apr 02 2018

Earnings vs. Estimates